| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 10/07/2004 | WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 10/07/2004 | WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | WO2004084824A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 10/07/2004 | WO2004084813A2 Chemical compounds |
| 10/07/2004 | WO2004084634A1 N-phenyl- ‘ (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
| 10/07/2004 | WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/07/2004 | WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 10/07/2004 | WO2004067528B1 Cyano anthranilamide insecticides |
| 10/07/2004 | WO2004065392A8 Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| 10/07/2004 | WO2004060362B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 10/07/2004 | WO2004046134A3 Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation |
| 10/07/2004 | WO2004045518A3 Open chain prolyl urea-related modulators of androgen receptor function |
| 10/07/2004 | WO2004026829A3 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibitors |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003072106A8 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | US20040198987 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use |
| 10/07/2004 | US20040198984 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198804 i.e., 3-[3,5-dimethyl-4-[3-oxo-3-(piperazin-1-ylpropyl]-1H-pyrrol-2-ylmethylene]-1,3-dihydroindol-2-one, in which the piperazine may be 4-substituted with methyl or ethyl and salts are tyrosine kinase inhibitors used to treat various kinds of cancer |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198771 medical equipment for angioplasty |
| 10/07/2004 | US20040198747 Sodium channel blockers |
| 10/07/2004 | US20040198746 Sodium channel blockers |
| 10/07/2004 | US20040198745 Sodium channel blockers |
| 10/07/2004 | US20040198744 Methods of using phenolic guanidine sodium channel blockers |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198739 Prevention reproduction of virus |
| 10/07/2004 | US20040198736 Non-nucleoside reverse transcriptase inhibitors |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198734 2-(4-Aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198730 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 10/07/2004 | US20040198724 Contacting a cell with a quinazolinones containing sulfur or its oxides in an amount sufficient to open the potassium channels for the treatment of central or peripheral nervous system disorders |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | US20040198701 EP4 receptor agonist, compositions and methods thereof |
| 10/07/2004 | US20040198609 Herbicides for plants and crops; agriculture |
| 10/07/2004 | US20040194227 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibres |
| 10/07/2004 | DE10312963A1 Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 4-Phenyltetrahydroisochinoline, processes for their preparation, their use as a medicament, and medicament containing them |
| 10/07/2004 | CA2520443A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | CA2520440A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | CA2519677A1 Biaryl substituted 6-membered heterocycles as sodium channel blockers |
| 10/07/2004 | CA2519658A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds |
| 10/07/2004 | CA2519401A1 Cannabinoid receptor ligands |
| 10/07/2004 | CA2519288A1 N-phenyl-[(4-pyridyl)- azinyl]amine derivatives as plant protection agents |
| 10/07/2004 | CA2519051A1 Water-soluble thalidomide derivatives |
| 10/07/2004 | CA2518909A1 Heterocyclic compounds and methods of use |
| 10/07/2004 | CA2518823A1 Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463724A1 Pyrrolidone carboxamides |
| 10/06/2004 | EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof |
| 10/06/2004 | EP1463506A1 Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1154993B1 Thioamide derivatives |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 10/06/2004 | EP1064270B1 Disubstituted pyrazolines and triazolines as factor xa inhibitors |
| 10/06/2004 | EP1032424B9 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 10/06/2004 | EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 10/06/2004 | EP0973704B1 Process for the manufacture of arylsulfonyl chloride |
| 10/06/2004 | EP0970070B1 Phthalazines with angiogenesis inhibiting activity |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1535267A 5-membered heterocycles, preparation and use thereof as medicine |
| 10/06/2004 | CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II |
| 10/06/2004 | CN1534035A Water soluble thalidomide derivrative |
| 10/06/2004 | CN1169807C Processes for preparation of pyridine derivs. |
| 10/06/2004 | CN1169798C Novel diazo alcoholic antifungal compound and its preparing process |
| 10/06/2004 | CN1169797C Antiviral phrimidinedione derivatives and process for preparation thereof |
| 10/06/2004 | CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition |
| 10/06/2004 | CN1169792C Substituted vinylpyridine derivatives and drugs containing the same |
| 10/06/2004 | CN1169791C Novel acetamide derivatives and protease inhibitors |
| 10/06/2004 | CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800728 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 10/05/2004 | US6800678 Flame retardant compositions |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | US6800646 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 10/05/2004 | US6800645 Substituted azabicyclic compounds |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800636 Farnesyl protein transferase inhibitors |
| 10/05/2004 | US6800628 Such as (1-(2-((3-methyl-2-pyrazinyl)amino)ethyl)-4-piperidinyl)-methyl-4-amino-5 -chloro-2,3-dihydro-7-benzofurancarboxylate |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800590 2-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses |
| 10/05/2004 | US6800273 Anticancer agents; angiogenosis inhibitors |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083204A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |